Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Thl‐like response in chronic hepatitis C
- 1 June 1999
- journal article
- Published by Wiley in Liver International
- Vol. 19 (3) , 212-219
- https://doi.org/10.1111/j.1478-3231.1999.tb00038.x
Abstract
Background/Aims: The involvement of a direct viral cytopathic effect or an immune‐mediated mechanism in the progression of hepatic damage in chronic hepatitis C is controversial. The type of immune response is itself a matter of controversy, and histological data are lacking. The aim of this study was to identify the factors associated with the progression of liver injury in 30 HCV/RNA‐positive untreated patients with chronic hepatitis. Methods: Necroinflammatory and architectural damage were evaluated using Ishak's score. Activated hepatic stellate cells (HSC) were visualized by immunohistochemistry for α‐smooth muscle actin (αSMA) and quantitated by morphometry. Plasma HCV/RNA was evaluated using a competitive RT‐PCR method. To study the type of immune response involved in the progression of liver injury, interferony (IFNγ)‐positive cells (as expression of a Th1‐like response) were evaluated by immunohistochemistry and quantitated by morphometry. Results: HSC were mostly detected close to areas of lobular necroinflammation or lining fibrotic septa. The αSMA‐ and Sirius Red‐positive parenchyma correlated significantly with necroinflammatory and architectural scores. IFNγ‐positive cells were detected in periportal areas associated with the inflammatory infiltrates and significantly correlated with architectural damage. No relationship was found between the histological features of liver injury and viral load. Conclusions: HSC activation and progression of liver injury are unrelated to viral load but associated with a Th1‐like response, a plausible target for the treatment of chronic hepatitis C.Keywords
This publication has 41 references indexed in Scilit:
- Interferon gamma treatment prevents procollagen gene expression without affecting transforming growth factor-β1 expression in pig serum-induced rat liver fibrosis in vivoJournal of Hepatology, 1998
- Hepatic stellate cell activation in genetic haemochromatosisJournal of Hepatology, 1997
- Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosisJournal of Hepatology, 1996
- Serum HCV RNA levels assessed by quantitative NASBA®: stability of viral load over time, and lack of correlation with liver diseaseJournal of Hepatology, 1996
- Liver stellate cells in chronic viral hepatitis: the effect of interferon therapyJournal of Hepatology, 1996
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- The Th1–Th2 hypothesis of HIV infection: new insightsImmunology Today, 1994
- Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infectionJournal of Hepatology, 1994
- ?-Smooth-muscle actin expression in normal and fibrotic human liversDigestive Diseases and Sciences, 1993
- Appearance of α‐smooth‐muscle‐actin‐positive cells in hepatic fibrosisLiver International, 1991